{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:39:04Z","timestamp":1792795144441,"version":"4.5.0"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Modification of surface antigens and differential expression of virulence factors are frequent strategies pathogens adopt to escape the host immune system. These escape mechanisms make pathogens a \u201cmoving target\u201d for our immune system and represent a challenge for the development of vaccines, which require more than one antigen to be efficacious. Therefore, the availability of strategies, which simplify vaccine design, is highly desirable. Bacterial Outer Membrane Vesicles (OMVs) are a promising vaccine platform for their built-in adjuvanticity, ease of purification and flexibility to be engineered with foreign proteins. However, data on if and how OMVs can be engineered with multiple antigens is limited. In this work, we report a multi-antigen expression strategy based on the co-expression of two chimeras, each constituted by head-to-tail fusions of immunogenic proteins, in the same OMV-producing strain. We tested the strategy to develop a vaccine against <jats:italic>Staphylococcus aureus<\/jats:italic>, a Gram-positive human pathogen responsible for a large number of community and hospital-acquired diseases. Here we describe an OMV-based vaccine in which four <jats:italic>S. aureus<\/jats:italic> virulent factors, ClfA<jats:sub>Y338A<\/jats:sub>, LukE, SpA<jats:sub>KKAA<\/jats:sub> and Hla<jats:sub>H35L<\/jats:sub> have been co-expressed in the same OMVs (CLSH-OMVs<jats:sub>\u039460<\/jats:sub>). The vaccine elicited antigen-specific antibodies with functional activity, as judged by their capacity to promote opsonophagocytosis and to inhibit Hla-mediated hemolysis, LukED-mediated leukocyte killing, and ClfA-mediated <jats:italic>S. aureus<\/jats:italic> binding to fibrinogen. Mice vaccinated with CLSH-OMVs<jats:sub>\u039460<\/jats:sub> were robustly protected from <jats:italic>S. aureus<\/jats:italic> challenge in the skin, sepsis and kidney abscess models. This study not only describes a generalized approach to develop easy-to-produce and inexpensive multi-component vaccines, but also proposes a new tetravalent vaccine candidate ready to move to development.<\/jats:p>","DOI":"10.3389\/fimmu.2021.752168","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T07:07:06Z","timestamp":1636355226000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Multi-Antigen Outer Membrane Vesicle Engineering to Develop Polyvalent Vaccines: The Staphylococcus aureus Case"],"prefix":"10.3389","volume":"12","author":[{"given":"Enrico","family":"K\u00f6nig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assunta","family":"Gagliardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilary","family":"Riedmiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Andretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Tomasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Irene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Frattini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Zanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Grandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Caproni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fantappi\u00e8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Grandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"key":"B1","volume-title":"Vaccines","author":"Plotkin","year":"2018"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines6010012","article-title":"Meningococcal Vaccines: Current Status and Emerging Strategies","volume":"6","author":"McCarthy","year":"2018","journal-title":"Vaccines"},{"key":"B3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1128\/MMBR.00031-09","article-title":"Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles","volume":"74","author":"Ellis","year":"2010","journal-title":"Microbiol Mol Biol Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.micres.2014.09.006","article-title":"Methods of Isolation and Purification of Outer Membrane Vesicles From Gram-Negative Bacteria","volume":"170","author":"Klimentov\u00e0","year":"2015","journal-title":"Microbiol Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M307628200","article-title":"Incorporation of Heterologous Outer Membrane and Periplasmic Proteins Into Escherichia Coli Outer Membrane Vesicles","volume":"279","author":"Kesty","year":"2004","journal-title":"J Biol Chem"},{"key":"B6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.copbio.2014.02.018","article-title":"Microbial Biosynthesis of Designer Outer Membrane Vesicles","volume":"29","author":"Baker","year":"2014","journal-title":"Curr Opin Biotechnol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2017.05.003","article-title":"Bioengineering Bacterial Outer Membrane Vesicles as Vaccine Platform","volume":"35","author":"Gerritzen","year":"2017","journal-title":"Biotechnol Adv"},{"key":"B8","doi-asserted-by":"publisher","first-page":"24015","DOI":"10.3402\/jev.v3.24015","article-title":"Antibody-Mediated Immunity Induced by Engineered Escherichia Coli OMVs Carrying Heterologous Antigens in Their Lumen","volume":"3","author":"Fantappi\u00e8","year":"2014","journal-title":"J Extracell Vesicles"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1905112116","article-title":"Bacterial Outer Membrane Vesicles Engineered With Lipidated Antigens as a Platform for Staphylococcus Aureus Vaccine","volume":"116","author":"Irene","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2017.00253","article-title":"Synergistic Protective Activity of Tumor-Specific Epitopes Engineered in Bacterial Outer Membrane Vesicles","volume":"7","author":"Grandi","year":"2017","journal-title":"Front Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.01941-14","article-title":"Decoration of Outer Membrane Vesicles With Multiple Antigens by Using an Autotransporter Approach","volume":"80","author":"Daleke-Schermerhorn","year":"2014","journal-title":"Appl Environ Microbiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro1289","article-title":"Immune Evasion by Staphylococci","volume":"3","author":"Foster","year":"2005","journal-title":"Nat Rev Microbiol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1424924112","article-title":"Vaccine Composition Formulated With a Novel TLR7-Dependent Adjuvant Induces High and Broad Protection Against Staphylococcus Aureus","volume":"112","author":"Bagnoli","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9010177","article-title":"Performance of a Four-Antigen Staphylococcus Aureus Vaccine in Preclinical Models of Invasive S. Aureus Disease","volume":"9","author":"Scully","year":"2021","journal-title":"Microorganisms"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro3521","article-title":"Staphylococcal Manipulation of Host Immune Responses","volume":"13","author":"Thammavongsa","year":"2015","journal-title":"Nat Rev Microbiol"},{"key":"B16","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-72063-0","volume-title":"Staphylococcus Aureus","author":"Bagnoli","year":"2017"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e12066","DOI":"10.1002\/jev2.12066","article-title":"Proteome-Minimized Outer Membrane Vesicles From Escherichia Coli as a Generalized Vaccine Platform","volume":"10","author":"Zanella","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"B18","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/2F978-1-59745-196-3_6","article-title":"The Polymerase Incomplete Primer Extension (PIPE) Method Applied to High-Throughput Cloning and Site-Directed Mutagenesis","volume":"498","author":"Klock","year":"2009","journal-title":"Methods Mol Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M116.065094","article-title":"Some Gram-Negative Lipoproteins Keep Their Surface Topology When Transplanted From One Species to Another and Deliver Foreign Polypeptides to the Bacterial Surface","volume":"16","author":"Fantappi\u00e8","year":"2017","journal-title":"Mol Cell Proteomics"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1128\/iai.58.7.2367-2374.1990","article-title":"Synthesis and Immunologic Properties in Mice of Vaccines Composed of Staphylococcus Aureus Type 5 and Type 8 Capsular Polysaccharides Conjugated to Pseudomonas Aeruginosa Exotoxin a","volume":"58","author":"Fattom","year":"1990","journal-title":"Infect Immun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.2.584-589.1992","article-title":"Comparative Immunogenicity of Conjugates Composed of the Staphylococcus Aureus Type 8 Capsular Polysaccharide Bound to Carrier Proteins by Adipic Acid Dihydrazide or N-Succinimidyl-3-(2-Pyridyldithio)Propionate","volume":"60","author":"Fattom","year":"1992","journal-title":"Infect Immun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.06.043","article-title":"Safety and Immunogenicity of a Booster Dose of Staphylococcus Aureus Types 5 and 8 Capsular Polysaccharide Conjugate Vaccine (StaphVAX \u00ae) in Hemodialysis Patients","volume":"23","author":"Fattom","year":"2004","journal-title":"Vaccine"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02369-14","article-title":"Protein A Suppresses Immune Responses During Staphylococcus Aureus Bloodstream Infection in Guinea Pigs","volume":"6","author":"Kim","year":"2015","journal-title":"MBio"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0404382101","article-title":"Staphylococcal Toxin Induced Preferential and Prolonged In Vivo Deletion of Innate-Like B Lymphocytes","volume":"101","author":"Goodyear","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2021.05.072","article-title":"A Protein A Based Staphylococcus Aureus Vaccine With Improved Safety","volume":"39","author":"Shi","year":"2021","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00230-12","article-title":"Protein A-Specific Monoclonal Antibodies and Prevention of Staphylococcus Aureus Disease in Mice","volume":"80","author":"Kim","year":"2012","journal-title":"Infect Immun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20092514","article-title":"Nontoxigenic Protein A Vaccine for Methicillin-Resistant Staphylococcus Aureus Infections in Mice","volume":"207","author":"Kim","year":"2010","journal-title":"J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-1033.1997.00416.x","article-title":"Characterization of the Interaction Between the Staphylococcus Aureus Clumping Factor (ClfA) and Fibrinogen","volume":"247","author":"Mcdevitt","year":"1997","journal-title":"Eur J Biochem"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1096\/fj.09-135467","article-title":"Genetic Requirements for Staphylococcus Aureus Abscess Formation and Persistence in Host Tissues","volume":"23","author":"Cheng","year":"2009","journal-title":"FASEB J"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e2206","DOI":"10.1371\/journal.pone.0002206","article-title":"Fibrinogen Binding Sites P336 and Y338 of Clumping Factor A are Crucial for Staphylococcus Aureus Virulence","volume":"3","author":"Josefsson","year":"2008","journal-title":"PloS One"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00354-12","article-title":"A Recombinant Clumping Factor A-Containing Vaccine Induces Functional Antibodies to Staphylococcus Aureus That are Not Observed After Natural Exposure","volume":"19","author":"Hawkins","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e00225","DOI":"10.1128\/mBio.00225-16","article-title":"Staphylococcus Aureus Clumping Factor a Remains a Viable Vaccine Target for Prevention of S. Aureus Infection","volume":"7","author":"Anderson","year":"2016","journal-title":"MBio"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e1002307","DOI":"10.1371\/journal.ppat.1002307","article-title":"Preventing Staphylococcus Aureus Sepsis Through the Inhibition of its Agglutination in Blood","volume":"7","author":"McAdow","year":"2011","journal-title":"PloS Pathog"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1128\/mr.55.4.733-751.1991","article-title":"Alpha-Toxin of Staphylococcus Aureus","volume":"55","author":"Bhakdil","year":"1991","journal-title":"Microbiol Rev"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5294.1859","article-title":"Structure of Staphylococcal \u03b1-Hemolysin, a Heptameric Transmembrane Pore","volume":"274","author":"Song","year":"1996","journal-title":"Science"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/toxins5061140","article-title":"Staphylococcus Aureus \u03b1-Toxin: Nearly a Century of Intrigue","volume":"5","author":"Berube","year":"2013","journal-title":"Toxins (Basel)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20072208","article-title":"Vaccine Protection Against Staphylococcus Aureus Pneumonia","volume":"205","author":"Wardenburg","year":"2008","journal-title":"J Exp Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1111084108","article-title":"Molecular Differentiation of Historic Phage-Type 80\/81 and Contemporary Epidemic Staphylococcus Aureus","volume":"108","author":"DeLeo","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1001815107","article-title":"Role of a Disintegrin and Metalloprotease 10 in Staphylococcus Aureus \u03b1-Hemolysin - Mediated Cellular Injury","volume":"107","author":"Wilke","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.462","article-title":"Genetic Requirement for ADAM10 in Severe Staphylococcus Aureus Skin Infection","volume":"132","author":"Inoshima","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1965.tb11633.x","article-title":"Staphylococcal Alpha Toxin","volume":"128","author":"Bernheimer","year":"1965","journal-title":"Ann N Y Acad Sci"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02220-19","article-title":"Protective Efficacy of Monoclonal Antibodies Neutralizing Alpha-Hemolysin and Bicomponent Leukocidins in a Rabbit Model of Staphylococcus Aureus Necrotizing Pneumonia","volume":"64","author":"Vu","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4161\/19420862.2014.985132","article-title":"Five Birds, One Stone: Neutralization of \u03b1-Hemolysin and 4 Bi-Component Leukocidins of Staphylococcus Aureus With a Single Human Monoclonal Antibody","volume":"7","author":"Rouha","year":"2015","journal-title":"MAbs"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.5.1843-1847.1994","article-title":"Site-Directed Mutagenesis of the Alpha-Toxin Gene of Staphylococcus Aureus: Role of Histidines in Toxin Activity In Vitro and in a Murine Model","volume":"62","author":"Menzies","year":"1994","journal-title":"Infect Immun"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00442-12","article-title":"Abscess Formation and Alpha-Hemolysin Induced Toxicity in a Mouse Model of Staphylococcus Aureus Peritoneal Infection","volume":"80","author":"Rauch","year":"2012","journal-title":"Infect Immun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro.2017.27","article-title":"Leukocidins: Staphylococcal Bi-Component Pore-Forming Toxins Find Their Receptors","volume":"15","author":"Spaan","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1128\/JB.01058-08","article-title":"Complete Genome Sequence of Macrococcus Caseolyticus Strain JSCS5402, Reflecting the Ancestral Genome of the Human-Pathogenic Staphylococci","volume":"191","author":"Baba","year":"2009","journal-title":"J Bacteriol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fuz030","article-title":"Development of a Vaccine Against Staphylococcus Aureus Invasive Infections: Evidence Based on Human Immunity, Genetics and Bacterial Evasion Mechanisms","volume":"44","author":"Miller","year":"2019","journal-title":"FEMS Microbiol Rev"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2116\/bunsekikagaku.26.252","article-title":"Phase Separation of Integral Membrane Proteins in Triton X-114 Solution","volume":"256","author":"Bordier","year":"1981","journal-title":"J Biol Chem"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis463","article-title":"Staphylococcus Aureus FhuD2 Is Involved in the Early Phase of Staphylococcal Dissemination and Generates Protective Immunity in Mice","volume":"206","author":"Mishra","year":"2012","journal-title":"J Infect Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0603940103","article-title":"A Universal Vaccine for Serogroup B Meningococcus","volume":"103","author":"Giuliani","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00134-14","article-title":"Staphylococcus Aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management","volume":"28","author":"Tong","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/femsre\/fux007","article-title":"Antibiotic Resistance in Staphylococcus Aureus. Current Status and Future Prospects","volume":"41","author":"Foster","year":"2017","journal-title":"FEMS Microbiol Rev"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2200","article-title":"Waves of Resistance: Staphylococcus Aureus in the Antibiotic Era","volume":"7","author":"Chambers","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.4161\/hv.34414","article-title":"Efficacy Profile of a Bivalent Staphylococcus Aureus Glycoconjugated Vaccine in Adults on Hemodialysis: Phase III Randomized Study","volume":"11","author":"Fattom","year":"2015","journal-title":"Hum Vaccines Immunother"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.3010","article-title":"Effect of an Investigational Vaccine for Preventing Staphylococcus Aureus Infections After Cardiothoracic Surgery: A Randomized Trial","volume":"309","author":"Fowler","year":"2013","journal-title":"JAMA - J Am Med Assoc"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4161\/hv.21872","article-title":"Development of a Multicomponent Staphylococcus Aureus Vaccine Designed to Counter Multiple Bacterial Virulence Factors","volume":"8","author":"Anderson","year":"2012","journal-title":"Hum Vaccines Immunother"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2011.04.006","article-title":"Trained Immunity: A Memory for Innate Host Defense","volume":"9","author":"Netea","year":"2011","journal-title":"Cell Host Microbe"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1098","article-title":"Trained Immunity: A Program of Innate Immune Memory in Health and Disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining Trained Immunity and its Role in Health and Disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.752168\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T07:07:23Z","timestamp":1636355243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.752168\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":60,"alternative-id":["10.3389\/fimmu.2021.752168"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.752168","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,8]]},"article-number":"752168"}}